BRAF and colorectal carcinoma: For example, BRAF mutations characterize about 10% of CRCs, with a similar rate in SBAs, however, while in CRC, BRAF V600E is by far the predominant mutation, it affects only 10.3% of BRAF-mutant SBAs [17,18].